| | | | | |
PYXS Pyxis Oncology, Inc. Common Stock | €2,9740 | +7,01% | €231,80M | €605,79K | |
AIFU AIFU Inc. Class A Ordinary Share | €9,5065 | +2,24% | €231,53M | €39,42K | |
PMO Franklin Municipal Opportunities Trust | €8,3809 | -0,82% | €231,53M | €28,02K | |
VABK Virginia National Bankshares Corporation Common Stock | €42,4935 | -0,28% | €231,19M | €7,49K | |
CAMP CAMP4 Therapeutics Corporation Common Stock | €3,6797 | +0,00% | €230,90M | €144,62K | |
| €12,2770 | -0,07% | €230,88M | €38,80K | |
| €8,2164 | +8,46% | €230,63M | €314,89K | |
DSP Viant Technology Inc. Class A Common Stock | €11,1818 | +2,66% | €230,19M | €214,93K | |
EGHT 8x8, Inc. Common Stock | €1,6017 | +0,54% | €230,09M | €1,20M | |
| €17,1428 | -4,49% | €229,76M | €117,70K | |
RILY BRC Group Holdings, Inc. Common Stock | €5,3939 | -5,61% | €229,71M | €643,05K | |
MIN Aberdeen Intermediate Income Fund | €2,0260 | +0,43% | €229,56M | €249,72K | |
TRDA Entrada Therapeutics, Inc. Common Stock | €6,1169 | +3,90% | €229,23M | €290,99K | |
| €3,6883 | +4,67% | €228,76M | €200,95K | |
OACC Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share | €9,3680 | +0,51% | €228,58M | €4,16K | |
